The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A decision support intervention for patients with advanced lung cancer amid growing therapeutic complexity: Results of a randomized controlled trial.
 
Matthias Villalobos
Research Funding - AstraZeneca (Inst)
 
Laura Unsoeld
No Relationships to Disclose
 
Nicole Deis
No Relationships to Disclose
 
Anja Siegle
No Relationships to Disclose
 
Michael Thomas
Honoraria - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda